Obesity Medicine 2026 - The Evolving Role of Medications in Pediatric and Adolescent Obesity Treatment (Recorded)

This session reviews cutting-edge evidence on pharmacologic options for pediatric and adolescent obesity, including new trial data and emerging therapies. Experts will discuss comparative efficacy, safety, and mechanisms of action, offering practical guidance for clinical use. Future research priorities and policy implications will also be explored to inform best practices in treating youth with obesity and metabolic complications.

CME/CE Expiration Date: 4/12/29

*The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation. 

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
    The Obesity Medicine Association (OMA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The Obesity Medicine Association designates this Enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the commensurate amount with the extent of their participation in the activity.
  • 1.00 Participation
Course opens: 
04/12/2026
Course expires: 
04/12/2029
Cost:
$25.00

Aaron Kelly, PhD

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
    The Obesity Medicine Association (OMA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The Obesity Medicine Association designates this Enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the commensurate amount with the extent of their participation in the activity.
  • 1.00 Participation

Price

Cost:
$25.00
Please login or register to take this course.

Required Hardware/software

For best user experience we recommend using a computer to complete this course.